HLA-C and neoplasm: While MHC defects play a role in primary resistance, another major factor influencing the outcome of TCR-transgenic T cell ACT is the aberrant activation of various signal transduction pathways, which ultimately confer an apoptosis-resistance phenotype to tumor cells.